ViewRay (VRAY) Announces Proposed $75M Public Offering of Common Stock

Go back to ViewRay (VRAY) Announces Proposed $75M Public Offering of Common Stock

ViewRay (VRAY) Prices 41.55M Share Common Offering at $3.13/Sh

December 4, 2019 5:40 AM EST

ViewRay, Inc. (NASDAQ: VRAY) today announced the pricing of an underwritten public offering of 41,550,000 shares of common stock at a price to the public of $3.13 per share, for gross proceeds of approximately $130.1 million, before deducting underwriting discounts and commissions and estimated offering expenses... More

Guggenheim Reiterates Buy Rating on ViewRay Inc. (VRAY)

December 3, 2019 9:01 AM EST

Guggenheim analyst Christopher Pasquale reiterated a Buy rating and $8.00 price target on ViewRay Inc. (NASDAQ: VRAY) after the company announced that it has entered into strategic collaborations with both Elekta (EKTAF) and MDT as part of a planned equity financing.

The analyst... More

Baird Reiterates Outperform Rating on ViewRay Inc. (VRAY); 'Financing Monkey Off the Back'

December 3, 2019 8:54 AM EST

Baird analyst Jason Bednar reiterated an Outperform rating and $6.00 price target on ViewRay Inc. (NASDAQ: VRAY) after the company announced proposed financing details, including a $75M raise in which Fosun, Elekta, and Medtronic will participate. As part of their investments, VRAY will partner... More

ViewRay (VRAY) to Resume Trading at 4:30 pm

December 2, 2019 4:14 PM EST

ViewRay (NASDAQ: VRAY) to Resume Trading at 4:30 pm

... More

ViewRay (VRAY) Reports Collaborations with Elekta and Medtronic (MDT)

December 2, 2019 4:04 PM EST

ViewRay, Inc. (Nasdaq: VRAY) announced today that it has signed a non-binding memorandum of understanding for collaboration with Elekta AB (Nasdaq: EKTA-B.ST) ("Elekta") to advance the knowledge and use of MR-guided radiation therapy. In connection with the collaboration, Elekta has committed to invest capital for up to a 9.9% minority interest in ViewRay, subject to the terms and conditions set forth in a commitment agreement.

Additionally, ViewRay has signed a non-binding memorandum of understanding with Medtronic (NYSE: MDT) to enter into a clinical collaboration in an... More

ViewRay (VRAY) Halted for News Disseminated

December 2, 2019 4:02 PM EST

ViewRay (NASDAQ: VRAY) Halted for News Disseminated

... More